Stocks
GlaxoSmithKline (GSK) Net Assets US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net Assets, £ | ? | 20 391 244 750 | 10 598 000 000 | 17 014 755 600 | 13 671 000 000 | 16 348 214 000 | 23 541 432 000 | ||
| Changes by years, y/y, % | +2% | -48% | +61% | -20% | +20% | -3.9% | |||
GlaxoSmithKline. Net Assets, £
GlaxoSmithKline. Net Assets, changes, %
GlaxoSmithKline (GSK) Net Assets US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net Assets, £ | ? | 18 273 147 750 | 20 268 846 850 | 21 739 245 000 | 16 348 214 000 | 23 541 432 000 | 23 541 432 000 | |
| Changes by years, y/y, % | +5% | +12% | +55% | +20% | +29% | |||
| Changes by quarters, q/q, % | +34% | +11% | +7% | -25% | +44% | |||
